Deutscher Wissenschaftsherold • German Science Herald, N 5/2017

DDC-UDC 616.36-003.8-085:615.32

 DOI:10.19221/2017514

THE POSSIBILITIES TO REDUCE CARDIOMETABOLIC RISK OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. ARE DRUGS ALWAYS ESEENTIAL?

Dragomyretska N.V.

Head of the Department of Medical Rehabilitation, Professor, Doctor of Medical Sciences; the State Institution «Ukrainian
Scientific-Research Institute of Medical Rehabilitation and Balneology, the Ministry of Public Health of Ukraine», Odesa,
izhaanna@mail.ru

Zabolotna I.B.

Senior scientific employee, Candidate of Medical Sciences, the Department of Medical Rehabilitation, the State Institution
«Ukrainian Scientific-Research Institute of Medical Rehabilitation and Balneology, the Ministry of Public Health of
Ukraine», Odesa, irina_z@ukr.net

Gushcha S.G.

Senior scientific employee, Candidate of Medical Sciences, the Department of Fundamental Investigations, the State
Institution «Ukrainian Scientific-Research Institute of Medical Rehabilitation and Balneology, the Ministry of Public Health
of Ukraine», Odesa, gushchasergey@rambler.ru

Nasibullin B.А.

Head of the Department of Fundamental Investigations, Professor, Doctor of Medical Sciences, the State Institution
«Ukrainian Scientific-Research Institute of Medical Rehabilitation and Balneology, the Ministry of Public Health of
Ukraine», Odesa, gushchasergey@rambler.ru

THE POSSIBILITIES TO REDUCE CARDIOMETABOLIC RISK OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. ARE DRUGS ALWAYS ESEENTIAL?